Abraham, Manja D.,
Hendrien L. Kaal, & Peter D.A. Cohen (2002), Licit and illicit
drug use in the Netherlands 2001. Amsterdam: CEDRO/Mets en Schilt.
Pp. 169-226.
© Copyright 2002 CEDRO Centrum
voor Drugsonderzoek.
[Press release]
[Index] [Previous
Chapter] [Next Chapter]
Licit and illicit drug use in the Netherlands
2001
Chapter 6: Use figures per drug
Manja D. Abraham, Hendrien
L. Kaal, & Peter D.A. Cohen
6.1 Introduction
This chapter provides some of the same data as the previous
chapter, but this time presented separately for each drug, and split for
different age groups. It was thought that this would make it easier to
get an overview of the use patterns of one particular drug. For each drug
the tables give the lifetime prevalence rates per age group and, if the
number of last month users permits it, the last month prevalence rates
per age group. Additionally, a summary of the core figures is given. Because
the figures have already been discussed in the previous chapter, only
the tables are presented here.
Tables
- Table
6.1: Tobacco use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.2: Alcohol use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.3: Hypnotics use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.4: Sedatives use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.5: Cannabis use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.6: Cocaine use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.7: Amphetamine use in the Netherlands in seven samples: Amsterdam,
Rotterdam, and five categories of address density municipalities, 1997
and 2001 (weighted percentages) / (index figures: 1997 = 100)
- Table
6.8: Ecstasy use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.9: Hallucinogens use in the Netherlands in seven samples: Amsterdam,
Rotterdam, and five categories of address density municipalities, 1997
and 2001 (weighted percentages) / (index figures: 1997 = 100)
- Table
6.10: LSD use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.11: Mushrooms use in the Netherlands in seven samples: Amsterdam,
Rotterdam, and five categories of address density municipalities, 1997
and 2001 (weighted percentages) / (index figures: 1997 = 100)
- Table
6.12: Opiates use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.13: Morphine use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.14: Codeine use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.15: Heroin use in the Netherlands in seven samples: Amsterdam, Rotterdam,
and five categories of address density municipalities, 1997 and 2001
(weighted percentages) / (index figures: 1997 = 100)
- Table
6.16: Inhalants use in the Netherlands in seven samples: Amsterdam,
Rotterdam, and five categories of address density municipalities, 1997
and 2001 (weighted percentages) / (index figures: 1997 = 100)
- Table
6.17: Smart drugs use in the Netherlands in seven samples: Amsterdam,
Rotterdam, and five categories of address density municipalities, 2001
(weighted percentages)
- Table
6.18: Herbal ecstasy use in the Netherlands in seven samples: Amsterdam,
Rotterdam, and five categories of address density municipalities, 2001
(weighted percentages)
- Table
6.19: Guarana, ginseng, kavakava, damiana, and colanut use in the Netherlands
in seven samples: Amsterdam, Rotterdam, and five categories of address
density municipalities, 2001 (weighted percentages)
- Table
6.20: Performance enhancing drug use in the Netherlands in seven samples:
Amsterdam, Rotterdam, and five categories of address density municipalities,
1997 and 2001 (weighted percentages) / (index figures: 1997 = 100)
- Table
6.21: Difficult drug use in the Netherlands in seven samples: Amsterdam,
Rotterdam, and five categories of address density municipalities, 1997
and 2001 (weighted percentages) / (index figures: 1997 = 100)
|